The Costs and Benefits of Community Thrombolysis for Acute Myocardial Infarction: A Decision-Analytic Model

Author： Luke Vale   Harvey Steffens   Cam Donaldson  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.14, 2004-01, pp. : 943-954

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombolysis Versus Primary Angioplasty in Older Patients with Acute Myocardial Infarction

By Maynard C.  

Drugs & Aging, Vol. 14, Iss. 6, 1999-06 ,pp. : 427-435

Adis International

Access to resources Recommend Favorite

Costs for Acute Myocardial Infarction in a Tertiary Care Centre and Nationwide in France

By Montagne O.  

PharmacoEconomics, Vol. 17, Iss. 6, 2000-06 ,pp. : 603-609

Adis International

Access to resources Recommend Favorite

Zofenopril: A Review of the Evidence of its Benefits in Hypertension and Acute Myocardial Infarction

By Borghi C.   Ambrosioni E.  

Clinical Drug Investigation, Vol. 20, Iss. 5, 2000-11 ,pp. : 371-384

Adis International

Access to resources Recommend Favorite

Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure: A Systematic Review

By Goehler Alexander   Geisler Benjamin P.   Manne Jennifer M.  

PharmacoEconomics, Vol. 29, Iss. 9, 2011-09 ,pp. : 753-769

Adis International

Access to resources Recommend Favorite

Alcohol and Acute Myocardial Infarction

By Biyik I   Ergene O  

The Journal of International Medical Research, Vol. 35, Iss. 1, 2007-01 ,pp. : 46-51

Field House Publishing

Access to resources Recommend Favorite